Immunoscore clinical utility to identify good prognostic colon cancer stage II patients with high-risk clinicopathological features for whom adjuvant treatment may be avoided Meeting Abstract


Authors: Galon, J.; Hermitte, F.; Mlecnik, B.; Marliot, F.; Bifulco, C. B.; Lugli, A.; Nagtegaal, I. D.; Hartmann, A.; Van den Eynde, M.; Roehrl, M. H. A.; Ohashi, P. S.; Zavadova, E.; Torigoe, T.; Patel, P. S.; Wang, Y. L.; Kawakami, Y.; Marincola, F.; Ascierto, P. A.; Fox, B. A.; Pages, F.
Abstract Title: Immunoscore clinical utility to identify good prognostic colon cancer stage II patients with high-risk clinicopathological features for whom adjuvant treatment may be avoided
Meeting Title: 2019 Gastrointestinal Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 4 Suppl.
Meeting Dates: 2019 Jan 17-19
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-02-01
Language: English
ACCESSION: WOS:000489107600493
DOI: 10.1200/JCO.2019.37.4_suppl.487
PROVIDER: wos
Notes: Meeting Abstract: 487 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael H Roehrl
    127 Roehrl